Neutral Market Analysis

Market Summary — Post market — 2026-09-08

September 8, 2026 8 min read

Tickers Mentioned

SOX AMD NYSE AMGN NVS NVDA AMZN INTC AI CPU+3 more

Key Takeaways

equities sold off to open the holiday-shortened trading week, with all three major averages finishing in negative territory on Tuesday, September 8
The Dow Jones Industrial Average led the decline, tumbling 628.18 points (-1.18%) to close at 52,786.07, while the S&P 500 fell 45.08 points (-0.58%) to 7,673.52 and the Nasdaq Composite slipped a more modest 85.58 points (-0.32%) to 26,442.46
The Russell 2000 (-0.5%) and S&P Mid Cap 400 (-0.7%) tracked roughly in line with the broader tape

Market Summary

U.S. equities sold off to open the holiday-shortened trading week, with all three major averages finishing in negative territory on Tuesday, September 8. The Dow Jones Industrial Average led the decline, tumbling 628.18 points (-1.18%) to close at 52,786.07, while the S&P 500 fell 45.08 points (-0.58%) to 7,673.52 and the Nasdaq Composite slipped a more modest 85.58 points (-0.32%) to 26,442.46. The Russell 2000 (-0.5%) and S&P Mid Cap 400 (-0.7%) tracked roughly in line with the broader tape.

The session’s dominant theme was renewed geopolitical escalation in the Middle East, which sent crude oil sharply higher and weighed on risk sentiment throughout the day. Reports of a U.S.-Iran strike exchange, a Houthi attack on a Saudi energy facility, and later-session headlines of U.S. strikes on Iranian oil tankers near Kharg Island kept crude bid into the close. Only two of the eleven S&P 500 sectors — Energy and Utilities — finished higher, while Health Care (-2.6%) and Financials (-1.4%) paced the downside, with Amgen’s double-digit decline dragging on the Dow in particular.

Beneath the index-level weakness, semiconductor strength provided a notable offset, with the Philadelphia Semiconductor Index (SOX) gaining 1.3% on company-specific catalysts from Intel, AMD, and Qualcomm. That relative strength helped the Information Technology sector limit its loss to just -0.2% and kept the Nasdaq’s decline in check relative to the Dow. Investors remained cautious ahead of a heavy data slate later in the week, with August PPI due Thursday and August CPI on Friday — both viewed as pivotal inputs ahead of next week’s FOMC meeting.

Market Snapshot

| Index | Level | Change | % Change |
|—|—|—|—|
| Dow Jones Industrial Average | 52,786.07 | -628.18 | -1.18% |
| S&P 500 | 7,673.52 | -45.08 | -0.58% |
| Nasdaq Composite | 26,442.46 | -85.58 | -0.32% |

Breadth (NYSE/Nasdaq Composite):

NYSE: Advancers 965, Decliners 1,778, Volume 1.22 bln
Nasdaq: Advancers 1,797, Decliners 3,152, Volume 6.17 bln

WaveFinder Breadth Metrics:

Primary Sentiment: Very Bullish | 4% Sentiment: Very Bearish | 40 SMA Sentiment: Bearish
Primary Bulls: 1,013 | Bears: 774
4% Bulls: 252 | Bears: 382
Above 20-day SMA: 47%
Above 40-day SMA: 38.9%
9-Month Bulls: 38 | Bears: 25 | Bull Follow-Through: 0%

YTD Performance:

Russell 2000: +19.3%
S&P Mid Cap 400: +13.7%
Nasdaq Composite: +13.7%
S&P 500: +12.1%
DJIA: +9.8%

Sector Performance

Energy and Utilities were the only two S&P 500 sectors to finish in positive territory. Health Care was the day’s clear laggard, driven by sharp declines in Amgen and biotech names following Novartis’s pipeline setbacks.

Key Earnings & Movers

Decliners:

Amgen (AMGN) — $393.17, -44.06 (-10.08%): Dragged lower by clinical trial fallout at Novartis, weighing heavily on biotech peers and the DJIA.
Novartis (NVS) — $137.70, -22.29 (-13.93%): Phase 3 failures for pelacarsen (HORIZON) and del-desiran (HARBOR) rattled confidence in the company’s pipeline; shares were down as much as 12% in the morning session.
NVIDIA (NVDA) — $225.73, -4.63 (-2.01%): Weakness among mega-cap tech despite broader semiconductor strength.
Amazon (AMZN) — $256.97, -1.54 (-0.60%): Slight decline despite announcing a multi-year custom silicon/optical agreement with Qualcomm.

Advancers:

Intel (INTC) — $104.47, +8.67 (+9.05%): Rallied on positive analyst commentary and reports of potential price increases.
Advanced Micro Devices (AMD) — $505.74, +28.17 (+5.90%): Gained on upbeat AI demand and server CPU commentary.
Qualcomm (QCOM) — $174.09, +5.35 (+3.17%): Rose on news of a multi-year Amazon agreement covering custom silicon and optical connectivity.
Lumentum (LITE) — $978.54, +97.28 (+11.04%): Surged on positive read-through from the Verizon-Corning optical infrastructure deal.
Coherent (COHR) — $301.88, +20.02 (+7.10%): Also benefited from optical sector strength.
Corning (GLW) — $165.99, +11.69 (+7.58%): Jumped after announcing a multi-billion dollar, multi-year optical fiber agreement with Verizon (2027–2032).
Verizon (VZ) — $50.41, +0.27 (+0.54%): Modest gain tied to the Corning fiber agreement.

After-Hours:

Braze (BRZE): Beat EPS by $0.03 and beat on revenue; provided Q3 (Sep) and FY26 guidance.

Other Notable Items:

GE Aerospace (GE): Announced acquisition of Precision Products from Warburg Pincus and Berkshire Partners for $11.75 billion in cash and debt.
Bloom Energy (BE), Everpure (P), Illumina (ILMN): Set to join the S&P 500 prior to the open on September 21.

Stock Spotlight

Novartis (NVS): Triple Pipeline Blow Shakes Investor Confidence

Novartis shares plunged 13.93% to $137.70 after a cascade of pipeline setbacks raised fundamental questions about the company’s R&D productivity. The 8,323-patient Phase III HORIZON trial found that pelacarsen, while effective at lowering Lp(a), failed to reduce the composite risk of cardiovascular death, non-fatal MI, non-fatal stroke, or urgent coronary revascularization versus placebo — a result that challenges the broader thesis of Lp(a) as a valid therapeutic target. Compounding the damage, the approximately 150-patient Phase III HARBOR trial for del-desiran failed to significantly improve video hand opening time in myotonic dystrophy type 1 patients, even as secondary and exploratory endpoints showed some activity.

The del-desiran failure is particularly consequential given it was the centerpiece asset of Novartis’s roughly $12 billion acquisition of Avidity Biosciences and had been viewed as a potential multibillion-dollar product validating CEO Vas Narasimhan’s M&A strategy. Combined with the company’s recent pause of eight of ten rap-cel (rapcabtagene autoleucel) studies following patient deaths, the market is reassessing confidence in Novartis’s broader development engine rather than treating these as isolated failures. Novartis maintained its 5-6% sales CAGR guidance for 2025-2030, and other pipeline assets — including delpacibart zotadirsen (FDA Priority Review for DMD44) and remibrutinib (positive Phase III MS data) — remain intact, but the next catalysts will be subgroup/secondary-endpoint data, regulatory feedback on del-desiran, and results of the rap-cel safety investigation. The spillover pressured related biotech names, including Amgen, which fell 10.08% on the day.

Bond Market & Treasuries

Treasuries began the week with modest losses, unable to sustain an early bounce despite crude oil pulling back from overnight highs near $95/bbl.

Yield Levels (settle):

2-year: 4.40% (+2 bps)
3-year: 4.47% (+2 bps)
5-year: 4.57% (+2 bps)
10-year: 4.81% (+2 bps)
30-year: 5.26% (+2 bps)

Key Drivers:

The U.S. Treasury opened this week’s auction slate with a solid $58 billion 3-year note sale: high yield 4.474% (vs. 3.764% prior 12-auction average), bid-to-cover 2.72 (vs. 2.66 average), indirect bid 62.1% (vs. 64.1% average), direct bid 26.9% (vs. 23.5% average).
A $39 billion 10-year note auction was scheduled for Wednesday.
The New York Fed’s August Survey of Consumer Expectations showed 3-year inflation expectations dipping to 3.2% from 3.3%, while 1-year (3.6%) and 5-year (3.0%) expectations were unchanged — data that had little market impact.
U.S. Dollar Index fell 0.4% to 98.83.
The Treasury sanctioned 36 entities tied to Iran’s aviation sector.
Market attention remains fixed on Thursday’s PPI and Friday’s CPI reports as key inputs for next week’s FOMC decision; per CME FedWatch, probability of a 25-bp hike stood at 58.4%.

Commodities

| Commodity | Price | Change | % Change |
|—|—|—|—|
| WTI Crude Oil | $93.02/bbl | +1.52 | +1.7% |
| Natural Gas | $2.92 | -0.06 | — |
| Gold | $4,438.90/ozt | -37.10 | -0.8% |
| Silver | $67.03 | +0.25 | — |
| Copper | $6.82/lb | +0.14 | +2.1% |

Crude oil settled at its highest level since late July, driven by escalating Middle East tensions, including reported U.S. strikes on Iranian oil tankers near Kharg Island and an Iranian attack on U.S. Navy ships. Gasoline prices topped $4.00/gallon nationally for the first time on Labor Day, while diesel hit a record $5.90/gallon.

Overseas Markets

Asia:

Nikkei: -1.7%
Hang Seng: -0.4%
Shanghai Composite: +0.2%

Europe:

DAX: -0.1%
FTSE 100: -0.1%
CAC 40: +0.1%

Key International Data/Drivers:

China’s August trade surplus reached CNY809.30 bln (vs. CNY805.00 bln expected; prior CNY767.07 bln); imports grew 28.2% yr/yr (vs. 30.0% expected), exports rose 25.0% yr/yr (as expected).
Japan’s Q2 GDP expanded 0.4% qtr/qtr (vs. 0.3% expected); Capital Expenditure fell 0.9% qtr/qtr; Private Consumption unchanged; July Overall Wage Income rose 4.7% yr/yr (vs. 3.9% expected).
Germany’s July trade surplus reached EUR21.3 bln (vs. EUR16.0 bln expected).
France’s July trade deficit widened to EUR6.7 bln (vs. EUR6.0 bln expected).
South Korea’s Q2 GDP grew 0.6% qtr/qtr and 3.7% yr/yr, both as expected.
The ECB is widely expected to announce a rate hike Thursday.

Economic Data

Total Consumer Credit (July): +$18.1 bln (Briefing.com consensus +$11.3 bln); June revised down to +$14.5 bln from +$14.2 bln.
NFIB Small Business Optimism Index (August): 98.7 (Briefing.com consensus 99.3), down from 99.8 in July.

Neither release had a material impact on today’s price action, with geopolitical and oil-driven themes dominating trading.

Looking Ahead

Wednesday, Sep 9: Weekly MBA Mortgage Index (7:00 ET; prior 0.8%); $39 billion 10-year Treasury note auction (13:00 ET).
Thursday, Sep 10: August Producer Price Index (PPI); ECB rate decision (widely expected to include a hike, with markets watching for December hike signals).
Friday, Sep 11: August Consumer Price Index (CPI) — viewed as the key input for the September 15-16 FOMC meeting; CME FedWatch currently prices a 58.4% probability of a 25-bp rate hike.
Ongoing: Continued monitoring of Middle East developments (U.S.-Iran tensions, Houthi activity) for further impact on oil prices and risk sentiment.
Sep 21: Bloom Energy (BE), Everpure (P), and Illumina (ILMN) join the S&P 500; Everpure replaces The Trade Desk (TTD).